Health Catalyst Inc (HCAT) financials
Health Catalyst revenue and earnings by year
Health Catalyst's revenue was $311 million in the fiscal year to December 31, 2025, up 1.5% from the year before. Net income was -$178 million, -57.2% of revenue. Since the fiscal year to December 31, 2017, revenue has grown 19.9% a year on average.
Fiscal years, each labelled by the calendar year it ended in.
Income statement, the last 9 fiscal years
| Fiscal year to | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 311 | 307 | 296 | 276 | 242 | 189 | 155 | 113 | 73 |
| Revenue growth | 1.5% | 3.6% | 7.1% | 14.2% | 28.1% | 21.9% | 37.6% | 54.0% | — |
| Gross profit | 152 | 141 | 132 | 133 | 118 | 91 | 80 | 53 | 29 |
| Gross margin | 48.7% | 45.9% | 44.5% | 48.2% | 48.6% | 48.1% | 51.4% | 46.8% | 40.3% |
| Operating income | -161 | -70 | -127 | -140 | -144 | -96 | -55 | -60 | -46 |
| Operating margin | -51.7% | -22.8% | -42.9% | -50.7% | -59.4% | -50.9% | -35.4% | -53.4% | -62.3% |
| Net income | -178 | -70 | -118 | -137 | -153 | -115 | -60 | -62 | -47 |
| Net margin | -57.2% | -22.7% | -39.9% | -49.7% | -63.3% | -60.9% | -38.8% | -55.1% | -64.4% |
| Diluted EPS | -$2.55 | -$1.15 | -$2.09 | -$2.63 | -$3.23 | -$2.91 | — | -$23.80 | — |
| Free cash flow | -20 | -1 | -46 | -50 | -40 | -35 | -35 | -43 | -39 |
Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open HCAT in Markets.
See also: HCAT returns
No forecast, no recommendation. This page describes Health Catalyst Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.